所属公司:EXUMA Biotech, Corp. 当前融资轮次:B+轮 成立日期:2015-01-01 所属地:米德兰 简介:EXUMA Biotechnology是一家为亚洲实体肿瘤市场开发CAR-T解决方案的临床阶段生物技术公司,于2016年4月成立,获得了F1 Oncology, Inc.的资本化和独家技术许可。EXUMA Biotechnology的成立旨在最大限度地发挥F1 Oncology在大...
EXUMA Biotech Corp., a clinical-stage biotechnology company discovering and developing CAR-T products and delivery solutions for liquid and solid tumors, today announced that preclinical data for the company's next-generation rapid point-of-care, or "rPO
/PRNewswire/ -- EXUMA Biotech, Corp., a clinical-stage biotechnology company discovering and developing cell and gene immunotherapies for solid and...
EXUMA Biotech, Corp. announced that its Chief Business Officer and Head of Finance, Dr. Gregory Wade, will provide a corporate presentation at 11:25 AM ET on Wednesday, September 14, 2022, as part of the annual Baird Global Healthcare Conference in New Yo...
EXUMA Biotech, Corp. announced that pre-clinical data from its solid-tumor subcutaneous CAR therapy program will be presented at the virtual 2022 Cancer Immunology and Immunotherapy Conference: Discovery to Mainstream Oncology hosted by the...